~14 spots leftby Mar 2026

Pre-Exercise Protein for Perimenopause

(MAAP Trial)

Recruiting in Palo Alto (17 mi)
AS
Overseen byAbbie Smith-Ryan, PhD
Age: 18 - 65
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of North Carolina, Chapel Hill
Must not be taking: Corticosteroids, Stimulants, Insulin, others
Disqualifiers: Cardiovascular disease, Diabetes, Hypertension, others

Trial Summary

What is the purpose of this trial?

This trial aims to compare the effects of high-intensity interval training (HIIT) and traditional aerobic exercise on metabolism in overweight or obese women going through perimenopause. The study will also look at how eating protein or carbohydrates before exercise affects these outcomes. The goal is to understand how these exercises and dietary choices can help manage weight and improve metabolic health during perimenopause. High-intensity interval training (HIIT) has been shown to significantly decrease body weight and fat mass, with more pronounced effects in premenopausal women.

Will I have to stop taking my current medications?

The trial requires that you stop taking metabolism-altering drugs or medications, except for estrogen replacement therapy, as they may influence study outcomes.

What data supports the effectiveness of the treatment Non-caloric Placebo water, Whey Protein Isolate, Whey Protein Isolate, WPI for perimenopausal women?

Research shows that milk whey protein, particularly its basic protein fraction, can improve bone health by increasing bone mineral density in perimenopausal women. This suggests that whey protein isolate, a component of the treatment, may help maintain or improve bone health in this population.12345

How does pre-exercise protein differ from other treatments for perimenopause?

Pre-exercise protein, particularly milk basic protein (MBP), is unique because it helps increase bone mineral density by promoting bone formation and inhibiting bone resorption, which is beneficial for bone health in perimenopausal women. This approach is different from other treatments as it focuses on maintaining bone health through dietary supplementation rather than medication.12678

Research Team

AS

Abbie Smith-Ryan, PhD

Principal Investigator

University of North Carolina

Eligibility Criteria

This trial is for early and late perimenopausal women aged 38 or older who are overweight (BMI: 28-40) with a body fat percentage of 30% or higher. They must be non-smokers, not currently pregnant or nursing, and have had changes in menstrual cycle regularity. Women with cardiovascular, metabolic disorders, recent weight fluctuations, or those on certain medications cannot participate.

Inclusion Criteria

Your body mass index (BMI) falls within the range of 28 - 40 Kg/m^2 and your percent body fat (%BF) is equal to or greater than 30%.
You are a non-smoker and in good physical health.
I am a woman over 38 experiencing changes in my menstrual cycle.

Exclusion Criteria

Has participated in another clinical trial within four weeks prior to enrollment that in the opinion of the PI would influence the results
Has severely impaired hearing or speech or inability to speak English
I have no major health issues or surgeries in the last 6 months that could affect my safety in the study.
See 11 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in high intensity interval training (HIIT) and traditional aerobic exercise, with pre-exercise carbohydrate or protein ingestion

8-12 weeks
Multiple visits for exercise sessions and assessments

Follow-up

Participants are monitored for metabolic responses, including energy expenditure and respiratory exchange ratio, after exercise

4 weeks

Treatment Details

Interventions

  • Non-caloric Placebo water (Other)
  • Whey Protein Isolate (Other)
Trial OverviewThe study tests how high intensity interval training (HIIT) versus traditional aerobic exercise affects metabolism in perimenopausal women when combined with pre-exercise consumption of either carbohydrates or protein. It aims to understand the impact on glucose levels, insulin sensitivity, energy expenditure, fat oxidation and muscle mass during this life stage.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Whey protein isolate, then Non-caloric placeboExperimental Treatment2 Interventions
Participants will randomly consume a whey protein isolate (Dymatize ISO-100) mixed with 6 oz of water prior to exercise. After a minimum of 48 hrs they will consume a non-caloric placebo (6 oz of water) prior to exercise.
Group II: Non-caloric placebo, then Whey protein isolatePlacebo Group2 Interventions
Participants will randomly consume a non-caloric placebo (6 oz of water) prior to exercise. After a minimum of 48 hrs they will consume a whey protein isolate (Dymatize ISO-100) mixed with 6 oz of water prior to exercise.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Applied Physiology Laboratory - University of North CarolinaChapel Hill, NC
Loading ...

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1588
Patients Recruited
4,364,000+

American Diabetes Association

Collaborator

Trials
148
Patients Recruited
102,000+

Findings from Research

[Prevention of osteoporosis by foods and dietary supplements. Milk basic protein (MBP) increases bone mineral density in young adult women and perimenopausal women].Itabashi, A.[2015]
Acute effects of whey protein isolate on cardiovascular risk factors in overweight, post-menopausal women.Pal, S., Ellis, V., Ho, S.[2015]
Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment.St Germain, A., Peterson, CT., Robinson, JG., et al.[2019]
Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study.Verhoeven, MO., van der Mooren, MJ., van de Weijer, PH., et al.[2021]
Dietary and Exercise Interventions for Perimenopausal Women: A Health Status Impact Study.Hao, S., Tan, S., Li, J., et al.[2022]
Whey protein and high-volume resistance training in postmenopausal women.Weisgarber, KD., Candow, DG., Farthing, JP.[2018]
Effect of Whey Protein Supplementation in Postmenopausal Women: A Systematic Review and Meta-Analysis.Kuo, YY., Chang, HY., Huang, YC., et al.[2022]
Effect of gender on the acute effects of whey protein ingestion on energy intake, appetite, gastric emptying and gut hormone responses in healthy young adults.Giezenaar, C., Luscombe-Marsh, ND., Hutchison, AT., et al.[2020]

References

[Prevention of osteoporosis by foods and dietary supplements. Milk basic protein (MBP) increases bone mineral density in young adult women and perimenopausal women]. [2015]
Acute effects of whey protein isolate on cardiovascular risk factors in overweight, post-menopausal women. [2015]
Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. [2019]
Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. [2021]
Dietary and Exercise Interventions for Perimenopausal Women: A Health Status Impact Study. [2022]
Whey protein and high-volume resistance training in postmenopausal women. [2018]
Effect of Whey Protein Supplementation in Postmenopausal Women: A Systematic Review and Meta-Analysis. [2022]
Effect of gender on the acute effects of whey protein ingestion on energy intake, appetite, gastric emptying and gut hormone responses in healthy young adults. [2020]